Results 21 to 30 of about 7,736 (213)

Comparing Trajectory of Surgical Aortic Valve Replacement in the Early vs. Late Transcatheter Aortic Valve Replacement Era

Frontiers in Cardiovascular Medicine, 2021
Background: Traditionally, the only effective treatment for aortic stenosis was surgical aortic valve replacement (SAVR). Transcatheter aortic valve replacement (TAVR) was approved in the United States in late 2011 and provided a critical alternative ...
Gabby Elbaz-Greener, Gabby Elbaz-Greener, Gabby Elbaz-Greener, Guy Rozen, Guy Rozen, Guy Rozen, Fabio Kusniec, Fabio Kusniec, Ibrahim Marai, Ibrahim Marai, Shemy Carasso, Shemy Carasso, Dennis T. Ko, Dennis T. Ko, Dennis T. Ko, Dennis T. Ko, Harindra C. Wijeysundera, Harindra C. Wijeysundera, Harindra C. Wijeysundera, Harindra C. Wijeysundera, Ronny Alcalai, David Planer, Offer Amir, Offer Amir, Offer Amir   +24 more
doaj   +1 more source

Trends and Outcomes of TAVI and SAVR in Cancer and Noncancer Patients

JACC: Advances, 2023
Patients with severe aortic stenosis and cancer are often denied surgical aortic valve replacement (SAVR) due to a prohibitive risk of perioperative mortality.The purpose of this study was to determine the safety of transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis and cancer.The Nationwide Inpatient Sample database
Waqas Ullah, Nishanth Thalambedu, Salman Zahid, Hamza Zahid Ullah Muhammadzai, Harigopal Sandhyavenu, Arnav Kumar, M. Chadi Alraies, Alec Vishnevsky, Nicholas J. Ruggiero, Mamas A. Mamas, Michael P. Savage, David L. Fischman   +11 more
openaire   +2 more sources

Recommendations on echocardiography following surgical aortic valve replacement (SAVR):time for revision?

, 2020
ESC guidelines recommend annual echocardiographic evaluation following biological surgical aortic valve replacement (SAVR), and 5 years following mechanical SAVR.
Sibilitz, Kirstine, Torp-Pedersen, C. L, Carranza, Christian L., Schmiegelow, M., Schmiegelow, S. S, Kober, L, Elming, Hanne, Torp-Pedersen, C.L, Dahl, J, Sibilitz, K, Dahl, Jordi, Bruun, N.E, Kober, Lars, Bruun, Niels Eske, Carranza, C.L, Schmiegelow, S.S, Elming, H, Schmiegelow, M, K Sibilitz, M Schmiegelow, H Elming, S.S Schmiegelow, J Dahl, C.L Torp-Pedersen, C.L Carranza, N.E Bruun, L Kober   +26 more
core   +1 more source

Changes in cerebral autoregulation and vasoreactivity after surgical aortic valve replacement: a prospective study

Experimental Physiology, 2023
Surgical aortic valve replacement (SAVR) alters the natural course of severe aortic stenosis (AS). In this study, we aimed to determine the effects of the disease on dynamic cerebral autoregulation and vasoreactivity (VR) and to assess their changes ...
Tiago Pedro, Andreia Costa, Juliana Ferreira, Ana Luísa Rocha, Elson Salgueiro, Gilberto Pereira, Elsa Azevedo, Pedro Castro   +7 more
doaj   +1 more source

TAVR and SAVR: Current Treatment of Aortic Stenosis [PDF]

Clinical Medicine Insights: Cardiology, 2012
Transcatheter aortic valve replacement (TAVR) was approved in the United States in late 2011, providing a critically needed alternative therapy for patients with severe aortic stenosis previously refused surgical aortic valve replacement (SAVR). Over 20,000 TAVR have been performed in patients worldwide since 2002 when Alain Cribier performed the first-
openaire   +4 more sources

Observed and adjusted racial/ethnic differences in the treatment of aortic stenosis (SAVR, TAVR).

, 2023
Observed and adjusted racial/ethnic differences in the treatment of aortic stenosis (SAVR, TAVR).
Yunus Ahmed (10777076), Pieter A. J. van Bakel (15203624), Michael P. Thompson (15203633), Devraj Sukul (8714460), Hechuan Hou (4622596), Donald S. Likosky (15203627), Gorav Ailawadi (8855985), Joost A. van Herwaarden (9708722), Himanshu J. Patel (10791599), Daphne C. Watkins (15203630)   +9 more
core   +1 more source

Meta‐analysis comparing valve‐in‐valve TAVR and redo‐SAVR in patients with degenerated bioprosthetic aortic valve

, 2021
Introduction: The comparative efficacy and safety of valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) and redo-surgical AVR (redo-SAVR) in patients with degenerated bioprosthetic aortic valves remain unknown.
Nishanth Thalambedu, Sameer Saleem, Mubbasher Ameer Syed, Salman Zahid, Divya Ratan Verma, Megaly, Michael, Zahid, Salman, Saleem, Sameer, Ullah, Waqas, Verma, Divya Ratan, Younas, Sundas, Salim S. Virani, Waqas Ullah, Alam, Mahboob, Mahboob Alam, Virani, Salim S., Michael Megaly, Mohammad Abdul‐Waheed, Thalambedu, Nishanth, Sundas Younas, Syed, Mubbasher Ameer, David L. Fischman   +21 more
core   +1 more source

Clinical Outcome of TAVI vs. SAVR in Patients with Severe Aortic Stenosis [PDF]

, 2023
The utilization of transcatheter aortic valve implantation (TAVI) has become the treatment of choice in patients with severe aortic stenosis (AS) with intermediate-to-high surgical risk for surgical aortic valve replacement (SAVR) [...
Wang, Zhen, Chayakrit Krittanawong, Fu’ad Al-Azzam, Joshua Hahn, Jneid, Hani, Krittanawong, Chayakrit, Al-Azzam, Fu\u27ad, Alam, Mahboob, Mahboob Alam, Sharma, Samin, Zhen Wang, Hafeez Ul Hassan Virk, Hani Jneid, Hahn, Joshua, Virk, Hafeez Ul Hassan, Samin Sharma   +15 more
core   +1 more source

Geographic and Demographic Variability in Transcatheter Aortic Valve Replacement Dispersion in the United States

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Transcatheter aortic valve replacement (TAVR) has transformed the management of aortic valve stenosis. However, little national data are available characterizing the geographic and demographic dispersion of this disruptive technology relative ...
Michael N. Young, Stephen Kearing, David Malenka, Philip P. Goodney, Jonathan Skinner, Alexander Iribarne   +5 more
doaj   +1 more source

RWT/SaVR-A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac Amyloidosis

, 2022
BACKGROUND: Cardiac amyloidosis is an underdiagnosed condition and simple methods for accurate diagnosis are warranted. We aimed to validate a novel, dual-modality approach to identify transthyretin cardiac amyloidosis (ATTR-CA), employing ...
Eldhagen, P,, Elsa Arnberg, Venkateshvaran, Ashwin, Per Eldhagen, Lindqvist, P, Ashwin Venkateshvaran, Eldhagen, Per,, Björn Pilebro, Löfbacka, Viktor,, Pilebro, B, Viktor Löfbacka, Arnberg, Elsa,, Arnberg, E, Löfbacka, Viktor, Per Lindqvist, Eldhagen, Per, Pilebro, Björn,, Lindqvist, Per,, Venkateshvaran, Ashwin,, Lofbacka, V, Lindqvist, Per, Pilebro, Björn, Arnberg, Elsa, Venkateshvaran, A,   +23 more
core   +1 more source